186 related articles for article (PubMed ID: 28411180)
1. Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.
Wang H; Kohashi K; Yoshizumi T; Okumura Y; Tanaka Y; Shimokawa M; Iwasaki T; Aishima S; Maehara Y; Oda Y
Hum Pathol; 2017 Jun; 64():69-75. PubMed ID: 28411180
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
[TBL] [Abstract][Full Text] [Related]
3. HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population.
Ler SY; Leung CH; Khin LW; Lu GD; Salto-Tellez M; Hartman M; Iau PT; Yap CT; Hooi SC
Oncol Rep; 2015 Nov; 34(5):2238-50. PubMed ID: 26352599
[TBL] [Abstract][Full Text] [Related]
4. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma.
Chen D; Li Z; Cheng Q; Wang Y; Qian L; Gao J; Zhu JY
J Clin Pathol; 2019 Sep; 72(9):588-596. PubMed ID: 31126975
[TBL] [Abstract][Full Text] [Related]
6. SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases.
Liu TC; Vachharajani N; Chapman WC; Brunt EM
Am J Surg Pathol; 2014 Jul; 38(7):966-72. PubMed ID: 24805857
[TBL] [Abstract][Full Text] [Related]
7. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
Yin F; Han X; Yao SK; Wang XL; Yang HC
World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
[TBL] [Abstract][Full Text] [Related]
8. Expression and significance of PTEN and miR-92 in hepatocellular carcinoma.
Zhao B; Zhu Y; Cui K; Gao J; Yu F; Chen L; Li S
Mol Med Rep; 2013 May; 7(5):1413-6. PubMed ID: 23546593
[TBL] [Abstract][Full Text] [Related]
9. Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.
Wu LM; Yang Z; Zhou L; Zhang F; Xie HY; Feng XW; Wu J; Zheng SS
PLoS One; 2010 Dec; 5(12):e14460. PubMed ID: 21206745
[TBL] [Abstract][Full Text] [Related]
10. Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma.
Qian YY; Liu ZS; Yan HJ; Yuan YF; Levenson AS; Li K
Biomed Pharmacother; 2018 May; 101():852-859. PubMed ID: 29635894
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma.
Rikimaru T; Taketomi A; Yamashita Y; Shirabe K; Hamatsu T; Shimada M; Maehara Y
Oncology; 2007; 72(1-2):69-74. PubMed ID: 18004079
[TBL] [Abstract][Full Text] [Related]
12. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
[TBL] [Abstract][Full Text] [Related]
13. MAT1A Suppression by the CTBP1/HDAC1/HDAC2 Transcriptional Complex Induces Immune Escape and Reduces Ferroptosis in Hepatocellular Carcinoma.
Li Y; Hu G; Huang F; Chen M; Chen Y; Xu Y; Tong G
Lab Invest; 2023 Aug; 103(8):100180. PubMed ID: 37230466
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
15. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
16. HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT.
Noh JH; Bae HJ; Eun JW; Shen Q; Park SJ; Kim HS; Nam B; Shin WC; Lee EK; Lee K; Jang JJ; Park WS; Lee JY; Nam SW
Cancer Res; 2014 Mar; 74(6):1728-38. PubMed ID: 24448241
[TBL] [Abstract][Full Text] [Related]
17. Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex.
Gao C; Dimitrov T; Yong KJ; Tatetsu H; Jeong HW; Luo HR; Bradner JE; Tenen DG; Chai L
Blood; 2013 Feb; 121(8):1413-21. PubMed ID: 23287862
[TBL] [Abstract][Full Text] [Related]
18. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Yong KJ; Gao C; Lim JS; Yan B; Yang H; Dimitrov T; Kawasaki A; Ong CW; Wong KF; Lee S; Ravikumar S; Srivastava S; Tian X; Poon RT; Fan ST; Luk JM; Dan YY; Salto-Tellez M; Chai L; Tenen DG
N Engl J Med; 2013 Jun; 368(24):2266-76. PubMed ID: 23758232
[TBL] [Abstract][Full Text] [Related]
19. X-radiation inhibits histone deacetylase 1 and 2, upregulates Axin expression and induces apoptosis in non-small cell lung cancer.
Han Y; Zhang Y; Yang LH; Mi XY; Dai SD; Li QC; Xu HT; Yu JH; Li G; Zhao J; Han C; Yuan XM; Wang EH
Radiat Oncol; 2012 Oct; 7():183. PubMed ID: 23110995
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.
Huang R; Zhang X; Sophia S; Min Z; Liu X
Anticancer Drugs; 2018 Apr; 29(4):364-370. PubMed ID: 29481474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]